GPT and diabetes mellitus: Elevated ALT (≥ 40 IU/L in men and ≥ 30 IU/L in women) was found in 13% of the cohort (n = 597), including 22% of people with diabetes, 20% of obese participants, and 17% of those with the metabolic syndrome.